Extendicare Inc. (TSE:EXE – Free Report) – Analysts at Leede Financial increased their FY2024 earnings estimates for shares of Extendicare in a research report issued to clients and investors on Wednesday, November 13th. Leede Financial analyst D. Loe now anticipates that the company will earn $1.03 per share for the year, up from their previous forecast of $0.89. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2027 earnings at $1.49 EPS.
Other research analysts also recently issued reports about the company. Royal Bank of Canada upped their target price on Extendicare from C$8.50 to C$9.50 in a research note on Monday, August 19th. TD Securities boosted their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a report on Thursday.
Extendicare Stock Performance
TSE EXE opened at C$10.14 on Friday. The company has a current ratio of 0.60, a quick ratio of 0.98 and a debt-to-equity ratio of 305.80. Extendicare has a twelve month low of C$6.41 and a twelve month high of C$10.43. The stock has a 50-day moving average of C$9.27 and a 200 day moving average of C$8.15. The stock has a market capitalization of C$846.39 million, a price-to-earnings ratio of 14.91 and a beta of 1.26.
Extendicare Dividend Announcement
The company also recently announced a monthly dividend, which was paid on Friday, November 15th. Shareholders of record on Thursday, October 31st were issued a dividend of $0.04 per share. The ex-dividend date was Thursday, October 31st. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.73%. Extendicare’s payout ratio is currently 70.59%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Read More
- Five stocks we like better than Extendicare
- Investing in the High PE Growth Stocks
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Most Volatile Stocks, What Investors Need to Know
- Top-Performing Non-Leveraged ETFs This Year
- Why Are These Companies Considered Blue Chips?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
